Beyond ‘test and treat’ – malaria diagnosis for improved pediatric fever management in sub-Saharan Africa

PHD REVIEW

Beyond ‘test and treat’ – malaria diagnosis for improved pediatric fever management in sub-Saharan Africa

Emily White Johansson*

Department of Women’s and Children’s Health, International Maternal and Child Health, Akademiska sjukhuset, Uppsala University, Uppsala, Sweden

Abstract

Background: Malaria rapid diagnostic tests (RDTs) have great potential to improve quality care and rational drug use in malaria-endemic settings although studies have shown common RDT non-compliance. Yet, evidence has largely been derived from limited hospital settings in few countries. This article reviews a PhD thesis that analyzed national surveys from multiple sub-Saharan African countries to generate large-scale evidence of malaria diagnosis practices and its determinants across different contexts.

Design: A mixed-methods approach was used across four studies that included quantitative analysis of national household and facility surveys conducted in multiple sub-Saharan African countries at the outset of new guidelines (Demographic and Health Surveys and Service Provision Assessments). Qualitative methods were used to explore reasons for quantitative findings in select settings.

Results: There was low (17%) and inequitable test uptake across 13 countries in 2009–2011/12, with greater testing at hospitals than at peripheral clinics (odds ratio [OR]: 0.62, 95% confidence interval [CI]: 0.56–0.69) or community health workers (OR: 0.31, 95% CI: 0.23–0.43) (Study I). Significant variation was found in the effect of diagnosis on antimalarial use at the population level across countries (Uganda OR: 0.84, 95% CI: 0.66–1.06; Mozambique OR: 3.54, 95% CI: 2.33–5.39) (Study II). A Malawi national facility census indicated common compliance to malaria treatment guidelines (85% clients with RDT-confirmed malaria prescribed first-line treatment), although other fever assessments were not often conducted and there was poor antibiotic targeting (59% clients inappropriately prescribed antibiotics). RDT-negative patients had 16.8 (95% CI: 8.6–32.7) times higher odds of antibiotic overtreatment than RDT-positive patients conditioned by cough or difficult breathing complaints (Study III). In Mbarara (Uganda), health workers reportedly prescribed antimalarials to RDT-negative patients if no other fever cause was identified and non-compliance seemed further driven by RDT perceptions, system constraints, and client interactions (Study IV).

Conclusions: A shift from malaria-focused test and treat strategies toward IMCI with testing is needed to improve quality care and rational use of both antimalarial and antibiotic medicines. Strengthened health systems are also needed to support quality clinical care, including adherence to malaria test results, and RDT deployment should be viewed as a unique opportunity to contribute to these important efforts.

Keywords: malaria; IMCI; child health; diagnosis; fever case management

Citation: Glob Health Action 2016, 9: 31744 - http://dx.doi.org/10.3402/gha.v9.31744

Copyright: © 2016 Emily White Johansson. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.

Received: 28 March 2016; Revised: 18 October 2016; Accepted: 24 October 2016; Published: 16 December 2016

Competing interests and funding: The author declares no competing interests.

*Correspondence to: Emily White Johansson, Department of Women’s and Children’s Health, International Maternal and Child Health, Akademiska sjukhuset, Uppsala University, SE-751 85 Uppsala, Sweden, Email: emily.johansson@kbh.uu.se

Introduction

Approximately 6 million children less than 5 years of age die annually worldwide, and half of these deaths occur in sub-Saharan Africa (1). These deaths are largely caused by complications during the newborn period or common infections that are both preventable and treatable, notably pneumonia, malaria, and diarrhea (2). A cornerstone of child survival programs, therefore, includes expanding access to early and effective treatment for these conditions, particularly to reach the poorest children at highest risk of death (3).

Evolution of treatment guidance for childhood illnesses

Efforts to effectively treat these conditions have historically been hampered by limited diagnostics available at peripheral clinics in order to identify the underlying cause of disease. Patients in these contexts are often treated on the basis of symptom presentations and simple clinical assessments, which, for many years, was guided by disease-specific protocols that did not account for comorbidities or symptom overlaps across disease conditions (4). This led to a growing recognition during the 1980s and the 1990s that integrated treatment protocols are essential for more appropriate and cost-effective management of the sick children.

Since the 1990s, the World Health Organization (WHO) and United Nations Children’s Fund (UNICEF) have promoted the Integrated Management of Childhood Illness (IMCI) guidelines, which provide an algorithm to help clinically manage the most common causes of child morbidity and mortality in an integrated manner (5). IMCI algorithms target the following common childhood conditions: malaria, pneumonia, diarrhea, dehydration, measles, malnutrition, anemia, and ear problems, among others. These guidelines also indicate danger signs of severe diseases that need immediate referral.

Fever is a common symptom of many of the abovementioned conditions. Yet, IMCI has historically recommended presumptive malaria treatment of pediatric fevers in malaria-endemic settings, given high malaria mortality rates, quick progression from clinical symptoms to death, and a lack of other defining features for clinical differentiation. Importantly, the presumption of all fevers as ‘malaria’ has been shown to impede probing for other causes of fever, notably pneumonia, which is also a leading cause of child deaths (6). Indeed, malaria and pneumonia have substantial symptom overlaps such that nearly all sick children with IMCI-classified pneumonia (cough with a breathing rate of 50 or more breaths per minute in children aged 2 to 12 months or 40 or more breaths per minute in children aged 12 months to 5 years) also had reported fever, or IMCI-classified malaria (7). Although these children should receive dual classifications and treatments for both conditions, studies have shown common mistreatment of IMCI-classified pneumonia with antimalarials, which delays appropriate care with potentially fatal consequences (8).

From clinical management to diagnostic confirmation of malaria

In 2010, the WHO revised malaria treatment guidelines to promote universal malaria diagnosis for all patients in all transmission settings with treatment based on the test result. This shift in guidelines was based on expert guidance and increasing availability of malaria rapid diagnostic tests (RDTs) that make diagnosis possible in peripheral clinics that previously lacked this capacity (9, 10). Malaria RDTs satisfy established criteria for assessing point-of-care diagnostic tests in terms of being affordable, sensitive, specific, user-friendly, robust, equipment-free, and deliverable to locations where diagnosis is most needed (11).

Many other reasons also supported the shift toward test-based malaria case management, notably the need to improve quality care for other fever causes as previously described (9). There has also been growing concerns about antimalarial drug resistance that is exacerbated by inappropriate prescriptions and poor adherence practices (12). Rising antimalarial drug costs also drive the need for better precision in treatment (13), and improved treatment targeting is particularly important in settings that significantly reduced malaria transmission in recent years where a lower fraction of fevers is now due to malaria (14). Finally, malaria surveillance has historically been hindered by imprecise case definitions based on reported fever symptoms such that recording only confirmed cases could improve malaria monitoring and burden estimation (9).

National programs have greatly invested in large-scale RDT deployment in recent years with the expectation of achieving these objectives (15). Yet, research from various settings has shown mixed program success (16). While most research generally indicates reduced antimalarial prescriptions after RDT introduction into health facilities, many adherence studies found common prescribing of antimalarial drugs to RDT-negative patients (16). In studies where first-line malaria treatment (artemisinin-based combination therapies [ACT]) was largely restricted to positive cases, some research further reported widespread prescriptions of second-line antimalarial or antibiotic medicines to negative test results and not according to established clinical guidelines (17, 18).

Thesis rationale and objectives

This evidence has largely been derived from small-scale adherence studies conducted in a limited set of countries, particularly Kenya, Malawi, Tanzania, Uganda, and Zambia (16). Although evidence has grown since the start of this doctoral project, there remains limited information for many countries that have comparably invested in RDT deployment (15, 16). Although a few countries have conducted national surveys to examine malaria testing practices across facility contexts (19, 20), there is still limited understanding of contextual differences and factors associated with RDT use and adherence. In addition, few facility studies have examined RDT integration into established clinical practice, or IMCI for sick children, to improve overall quality care for febrile children. Finally, and importantly, pediatric fevers in these settings are commonly managed at informal sources within communities, and initial RDT deployment targeted only formal health system sources (21). This could potentially result in low testing rates among the general population, which had not been adequately documented given the primary focus on facility-based research.

The PhD thesis emerged from the identification of these critical evidence gaps coupled with an awareness of new malaria diagnosis data collection in nationally representative population- and facility-based surveys routinely implemented across low- and middle-income countries (Demographic and Health Surveys [DHS], Malaria Indicator Surveys [MIS] and Service Provision Assessments [SPA]) (22, 23). The PhD thesis aimed to use these new data to answer some of these important research questions and to combine with qualitative research to better understand reasons for observed practices. Specific research questions included are as follows:

  • What are the extent and determinants of malaria diagnostic test use for pediatric fevers in 13 sub-Saharan African countries? How do malaria risk and the source of care influence test uptake? (Study I)
  • Does malaria testing reduce antimalarial drug use and increase antibiotic use for pediatric fevers at the population level? Are there effect differences across countries and what are the reasons for variation? (Study II)
  • How are sick children with fever complaints assessed and treated using RDT and IMCI during outpatient consultations in Malawi health facilities? What factors are associated with poor treatment decisions for clients with fever symptoms (e.g. antibiotic or antimalarial overtreatment)? (Study III)
  • How do health workers manage RDT-negative febrile children in the low-risk areas of Mbarara District (Uganda)? What are perceived challenges in this work and what are some desires for additional support or tools to help manage these cases? (Study IV)

Conceptual framework

The conceptual framework for the PhD thesis embedded a bottleneck analysis into the standard monitoring and evaluation (M&E) framework for assessing health system performance (24, 25) (Fig. 1). The bottleneck analysis highlights underlying factors at intermediate stages of service delivery – access, facility readiness, and clinical practice – that could impede achievement of expected outcomes and impact defined in the M&E framework.

Fig 1

Fig. 1.   Conceptual framework.

Access bottlenecks refer to geographic, financial, or socioeconomic barriers to using health services where malaria diagnosis is available. Facility readiness bottlenecks refer to facility or system constraints, such as guidelines, staffing, training, and referral systems, for using malaria diagnosis to improve pediatric fever management. Clinical practice bottlenecks refer to issues during the clinical encounter, such as perceptions, motivations, and client interactions, that could impede employing malaria diagnosis as intended by guidelines.

Some advantages of this modification for the PhD thesis included capturing access bottlenecks that are not explicitly measured in the standard M&E framework. In addition, the standard M&E framework quantitatively measures inputs to a system and their resulting outputs, outcomes, or impact. Yet, impediments to effective service delivery may reflect underlying perceptions or motivations that are not easily quantified and better captured using qualitative methods as part of a bottleneck analysis.

Methods

A mixed-methods approach was used across the four studies in the PhD thesis. Table 1 summarizes the different methodologies used across the four studies that are further described in the published articles (2629).


Table 1.  Methods overview
Study Design Data source Sample size Methods Outcomes, main predictors, and themes
I Meta-analysis
13 national cross-sectional population-based surveys
DHS and MIS in 13 countries in 2009–2011/12 27,916 febrile children under 5 years in 13 countries (2009–2011/12) Mixed-effects logistic regression models in the pooled data set for 13 countries Outcome(s):
Malaria diagnostic test uptake
Main predictor(s):
Malaria risk and source of care
II Mixed-methods
Quantitative: national cross-sectional population-based surveys
Qualitative: Country case studies
Quantitative
DHS in 12 countries 2010–2012

Qualitative:
Expert consultations; document reviews; published research
Quantitative
16,323 febrile children under 5 years and taken to care in 12 countries (2010–2012)
Qualitative:
six country case studies
Quantitative
Mixed-effects logistic regression models in individual country datasets

Qualitative:
Multiple case studies leading to a cross-case synthesis. Thematic analysis identified recurring themes
Quantitative
Outcome(s):
ACT use, any antimalarial use, any antibiotic use
Main predictor(s):
Malaria test uptake
Qualitative (themes): RDT deployment; health system structure; malaria epidemiology; RDT practice perceptions
III Data mining national facility census Malawi SPA 2013–2014 977 audited facilities; 2,950 observed sick child clients 2–59 months in first visit for illness Classification trees using model-based recursive partitioning Outcome(s):
Antibiotic and antimalarial overtreatment
Main predictor(s):
RDT results
IV Qualitative In-depth interviews and FGDs in Mbarara District, Uganda 20 health worker interviews; 7 caregiver focus group discussions Latent content analysis Qualitative (themes)
RDT perceptions, strategies to differentiate fever causes, desires for other tools or support, perceived challenges
DHS, Demographic and Health Surveys; MIS, Malaria Indicator Surveys; ACT, artemisinin-based combination therapies; RDT, rapid diagnostic tests; FGD, focus group discussions; SPA, service provision assessments.

Data sources

Three (of four) PhD studies analyzed the DHS, MIS, or SPA that are nationally representative population- and facility-based cross-sectional surveys routinely implemented in low- and middle-income countries. These survey programs and their methodologies are described elsewhere (22, 23). The fourth PhD paper was a qualitative study conducted in Mbarara District, Uganda, as described below.

Study settings

Study I included 13 sub-Saharan African countries using DHS and MIS conducted in 2009–2011/12. Study II was based on 12 sub-Saharan African countries using DHS conducted in 2010–2012. Study III analyzed the Malawi national facility census from 2013 to 2014 that included both public and private sources. Study IV was a qualitative study conducted in Mbarara District that included in-depth interviews with health workers at peripheral clinics and focus group discussions (FGD) with caregivers living in facility catchment areas. Mbarara District has low malaria prevalence (30) and is located 270 km southwest of the capital city. Mbarara is mostly a rural area with subsistence agriculture that has grown in recent years due to its central location as a transport hub to neighboring countries. The district includes 58 health facilities, both public (49) and private (9), as well as community health workers and private drugs shops that are commonly used to obtain medicines (31, 32). Figure 2 shows the countries included in these different studies.

Fig 2

Fig. 2.   Map of countries.
Dark blue (Study I countries); light blue (Study II countries); medium blue (Studies I and II countries).
Study I included Angola (MIS 2011), Burkina Faso (DHS 2010–2011), Burundi (DHS 2010–2011), Lesotho (DHS 2009–2010), Liberia (MIS 2011), Madagascar (MIS 2011), Malawi (DHS 2010), Nigeria (MIS 2010), Rwanda (DHS 2010–2011), Senegal (DHS 2010–2011), Tanzania (AIS/MIS 2011–2012), Uganda (DHS 2011), and Zimbabwe (DHS 2010–2011).
Study II included Benin (DHS 2011–2012), Burkina Faso (DHS 2010–2011), Burundi (DHS 2010–2011), Cote d’Ivoire (DHS 2011–2012), Gabon (DHS 2012), Guinea (DHS 2012), Malawi (DHS 2010), Mozambique (DHS 2011), Rwanda (DHS 2010–2011), Senegal (DHS 2010–2011), Uganda (DHS 2011), and Zimbabwe (DHS 2010–2011).
Study III analyzed a Malawi national facility census (2013–2014).
Study IV was a qualitative study in Uganda (Mbarara District).

Malaria diagnosis definitions

In DHS and MIS used in Studies I–II, malaria diagnosis receipt was based on caregiver responses that his or her child less than 5 years old with a reported fever episode in the previous 2 weeks received a finger or heel stick for testing, which refers to RDT or microscopy for malaria diagnosis. In SPA used in Study III, malaria diagnostic test use derived from provider reports that an RDT was performed before or during the consultation, and if so, the RDT result was subsequently reported. Referral for malaria diagnosis is based on caregiver reports during the exit interview that the provider instructed him or her to take the child to another provider or to go to the laboratory in this facility for a finger or heel stick for blood testing.

Treatment definitions

In DHS used in Study II, treatment outcomes included ACT use, any antimalarial use, and any antibiotic use. These treatment outcomes were based on reported drugs taken by children under age 5 with a febrile illness in the previous 2 weeks. In SPA used in Study III, antibiotic overtreatment was the main outcome, which was defined as any antibiotic prescription ‘without antibiotic need’ or excluding clients with IMCI pneumonia based on re-examination (see definition in the Introduction section) and additionally excluding clients diagnosed with the following conditions during the consultation: sepsis, dysentery, acute ear infection, mastoiditis, abscess, or severe malnutrition.

Data analysis

Study I was a meta-analysis of 13 DHS and MIS using mixed-effects logistic regression models to quantify the influence of source of care, malaria risk, and other socioeconomic variables on malaria diagnostic test use for pediatric fevers in combined and individual country data sets (Table 1).

Study II analyzed individual country data sets from 12 DHS using mixed-effects logistic regression models to separately quantify the influence of malaria diagnostic test use for pediatric fevers on three binary outcomes: ACT use, any antimalarial use, and any antibiotic use. A multiple case study design was employed to plausibly explain unexpected findings from six countries, which led to a cross-case synthesis to identify common themes that could explain contrasting country results (33) (Table 1).

Study III analyzed a Malawi national facility census to assess integrated pediatric fever management among children aged 2 months to 5 years in terms of other complaints, assessments completed and drug prescriptions for RDT-confirmed malaria, IMCI pneumonia, and clinical diarrhea. Classification trees using model-based recursive partitioning analyzed the effect of RDT results on antibiotic overtreatment and learned the influence of 38 other partitioning variables on this relationship at the patient, provider, and facility levels (34, 35). Classification trees are well-suited for this analysis since there may be numerous influences on the examined relationships of RDT results and antibiotic over-treatment, including potentially complex interactions among these 38 variables that are not easily detected using standard statistical methods and where there is no clear hypothesis about these sub-group interactions for statistical testing. Model-based recursive partitioning, in particular, embeds a parametric model into a recursive partitioning algorithm used in classification trees in order to automatically detect subgroup interactions with the binary outcome of antibiotic overtreatment. This is carried out by initially fitting a crude mixed-effects logistic regression model to the full data set and specifying the 38 input variables for repeated testing in order to partition the data set into subgroups where there may be different patterns of association between the main exposure and outcome. Parameter instability is repeatedly assessed across these partitioning variables and the data set is partitioned into nodes (or subgroups) according to the variable causing the highest instability. This automatic process is repeated at each node until no additional significant classifiers are identified using a Bonferroni-adjusted significance level of 0.05 or the minimal node size of 20 observations is reached. The parametric model is refit to each identified node yielding a series of segmented parametric models, including odds ratios or other coefficients that estimate the association between the main exposure and the outcome across each identified node or subgroup (Table 1).

Study IV was a qualitative study in Mbarara District, which included 20 health worker interviews at lower level clinics and seven FGD with caregivers living in facility catchment areas. Interviews were based on a semi-structured guide to capture how non-malaria pediatric fevers are currently managed in this district, perceived challenges in this work, and desires for additional tools or support. Caregivers were asked about their RDT experiences, perceptions of pediatric fever causes, and the acceptability of withholding antimalarials for RDT-negative cases. A latent content analysis approach was used to analyze interviews and FGD transcripts (36) (Table 1).

Results

Thesis findings are summarized according to bottleneck stages outlined in the conceptual framework that could hamper the effective use of malaria diagnosis for improved pediatric fever management: access, facility readiness, and clinical practice.

Access

Malaria diagnostic test use for pediatric fevers was low (17%) and inequitable across 13 countries in 2009–2011/12. This analysis included 105,791 children under 5 years of age, of which 27% had a reported fever in the previous 2 weeks. Table 2 highlights that seeking care from peripheral or informal sources significantly reduced the odds of malaria test receipt, which indicates an important access bottleneck. There was significantly lower testing odds if the febrile children were taken to a non-hospital formal source (odds ratio [OR]: 0.62, 95% confidence interval [CI]: 0.56–0.69) or community health worker (OR: 0.31, 95% CI: 0.23–0.43) compared to hospital attendance. Other important socioeconomic inequities were also identified, which further suggest this access bottleneck. Children with fever living in wealthiest households had higher testing odds than those in poorest households (OR 1.63: 95% CI: 1.39–1.91), and febrile children with mothers having at least secondary education had higher testing odds than those with mothers who had no formal education (OR: 1.33, 95% CI: 1.16–1.54). Living in high-risk areas also reduced the odds of testing compared with living in low risk areas (OR: 0.51, 95% CI: 0.42–0.62).


Table 2.  Effect of source of care, malaria endemicity, and socioeconomic variables on test uptake in 13 studied countries in 2009–2011/12
    Adjusted OR (95% CI) p value
Source of care Hospital 1.00    
  Non-hospital formal medical 0.62 (0.56–0.69) <0.001
  Community health worker 0.31 (0.23–0.43) <0.001
  Pharmacy 0.06 (0.05–0.09) <0.001
  Other 0.10 (0.08–0.13) <0.001
  No care sought 0.05 (0.04–0.06) <0.001
Malaria endemicity No transmission 0.46 (0.34–0.63) <0.001
  Unstable 1.32 (0.11–15.50) 0.823
  Low stable 1.00    
  Moderate stable 1.04 (0.86–1.25) 0.697
  High stable 0.51 (0.42–0.62) <0.001
Child’s age (in months) 0–5 0.72 (0.59–0.87) 0.001
  6–11 1.00    
  12–23 1.24 (1.09–1.41) 0.001
  24–35 1.27 (1.11–1.45) <0.001
  36–47 1.10 (0.95–1.26) 0.203
  48–59 1.18 (1.02–1.37) 0.030
Child’s sex Male 1.00    
  Female 0.98 (0.91–1.06) 0.676
Maternal age (in years) 15–24 1.00    
  25–29 1.01 (0.91–1.12) 0.891
  30–34 1.06 (0.94–1.20) 0.336
  35–39 1.06 (0.92–1.21) 0.425
  40–49 0.99 (0.83–1.17) 0.890
Maternal education No attendance 1.00    
  Primary 1.32 (1.19–1.46) <0.001
  Secondary or higher 1.33 (1.16–1.54) <0.001
Household wealth Poorest 1.00    
  Second 0.99 (0.87–1.13) 0.850
  Middle 1.03 (0.90–1.18) 0.670
  Fourth 1.21 (1.06–1.40) 0.006
  Least poor 1.63 (1.39–1.91) <0.001
Household members 0–4 members 1.00    
  5–8 members 0.95 (0.86–1.05) 0.307
  9–12 members 0.87 (0.76–0.99) 0.036
  13 or more members 0.66 (0.54–0.80) <0.001
Residence Urban 1.00    
  Rural 0.71 (0.62–0.82) <0.001
Mixed-effects logistic regression model in pooled data set of 13 surveys, adjusted for data clustering and above covariates. Unstable malaria transmission refers to areas of very low but non-zero transmission. Stable transmission categories refer to low (PfPR2–10 <5%), moderate (PfPR2–10 5–40%), and high (PfPR2–10>40%).
CI, confidence interval; AOR, adjusted odds ratio.

The access bottleneck was further identified in the study that related malaria diagnosis to changing drug use patterns for pediatric fevers at the population level. These results indicated that no country reduced ACT use associated with testing as hypothesized, and significant country variability was found in the impact of testing on pediatric fever treatment (Uganda OR: 0.84, 95% CI: 0.66–1.06; Mozambique OR: 3.54, 95% CI: 2.33–5.39). Four common themes explained varying findings across countries: available diagnostics and medicines, quality of care, care-seeking behavior, and malaria epidemiology. Available diagnostics and medicines are a theme relating to access bottlenecks and were a central explanation for results across country case studies. Indeed, children getting tested were probably at locations that also had medicines. In some countries, diagnostic services were only available at hospitals that likely also had better drug availability and may have been attended by patients with more severe illnesses. Taken together, these factors could greatly increase the treatment likelihood in these countries, which further indicates an important access bottleneck.

Facility readiness and clinical practice

Facility readiness and clinical practice bottlenecks are often intertwined and are therefore explored together in this section by presenting results separately from quantitative and qualitative studies in Malawi and Uganda, respectively.

Integrated pediatric fever management in Malawi health facilities

Integrated pediatric fever management using RDT and IMCI was examined in sick child observations of a national facility census conducted in Malawi in 2013–2014. This census included 977 facilities out of 1,060 on the Ministry of Health master list. A total of 2,950 sick children aged 2–59 months visiting for a first-time illness were observed and 1,981 had reported fever complaints during the exit interview. Among these 1,981 clients with fever, 1,436 (72%) reported cough or difficult breathing (CDB) complaints, 569 (29%) reported diarrhea complaints, and 359 (18%) reported other issues such as skin, eye, and ear problems. Any danger sign was reported among 1,021 clients (52%) with fever complaints. Only 117 (6%) reported fever alone with no other complaints or danger signs.

Among 1,981 febrile clients, 1,426 (72%) had RDT performed or were referred for malaria diagnosis, 44 (2%) had their necks checked for stiffness, 524 (27%) had palms checked for pallor, 185 (9%) were checked for mouth disorders, and 563 (28%) were undressed for examination. Among 1,436 clients with both fever and CDB complaints, 256 (18%) had breathing rates counted for 60 s (Table 3).


Table 3.  Completed assessments of clients with fever complaints, Malawi health facilities, 2013–2014
  N % assessed (95% CI)
Fever complaint 1,981  
  Fever mentioned or asked about by provider 1,684 85.0 (82.8–87.2)
  Temperature taken or body felt for hotness 1,386 70.0 (65.5–74.1)
  RDT done prior to consultation or referral for malaria diagnosis 1,426 72.0 (69.0–74.7)
  Checked neck for stiffness 44 2.2 (1.4–3.5)
  Checked for pallor by looking at palms 524 26.5 (23.5–29.6)
  Looked into child’s mouth 185 9.3 (7.4–11.6)
  Undressed child to examine (up to shoulders or down to ankles) 563 28.4 (25.2–31.9)
Fever and CDB complaint 1,436  
  Both symptoms mentioned or asked about by provider 1,010 70.3 (66.7–73.7)
  Counted breaths for 60 s 256 17.8 (14.8–21.2)
Fever and diarrhea complaint 569  
  Both symptoms mentioned or asked about by provider 307 53.9 (48.3–59.4)
  Checked skin turgor for dehydration 98 17.3 (13.3–22.1)
Symptom complaints are based on caregiver reports during exit interviews. Completed assessments are based on recorded observations during consultations. Point estimates are weighed to account for unequal probabilities of selection due to differing client volumes on the interview date. Standard error estimation accounted for clustering of client observations within facilities.
CI, confidence interval; RDT, rapid diagnostic tests; CDB, cough or difficult breathing.

Tables 4 and 5 show that 312 febrile clients had a reported RDT-positive result, and 265 (85%) with RDT-confirmed malaria were prescribed first-line antimalarial treatment, while 25 (8%) received no antimalarial prescription (antimalarial undertreatment). Among 434 with reported RDT-negative results, 44 (10%) were prescribed any antimalarial drug (antimalarial overtreatment). Among 376 with IMCI pneumonia based on re-examination, 148 (39%) received first-line antibiotic treatment and 105 (28%) received no antibiotic prescription (antibiotic undertreatment). A total of 1,411 clients were categorized as ‘without antibiotic need’, who did not have IMCI pneumonia based on re-examination and were not given the following diagnoses during the consultation: sepsis, acute ear infection, mastoiditis, dysentery, abscess, and severe malnutrition. Among these clients ‘without antibiotic need’, 830 (59%) were prescribed any antibiotic drug (antibiotic overtreatment).


Table 4.  Antimalarial prescriptions for clients with fever complaints, Malawi health facilities, 2013–2014
  N % with prescription (95% CI)
Fever complaint 1,981  
RDT done prior to consultation or malaria diagnosis referral 1,426  
RDT done prior to consultation with result reported 746  
RDT-positive result 312  
  First-line antimalarial prescription 265 85.1 (77.5–90.4)
  Second-line antimalarial prescription 22 7.0 (4.4–10.8)
  No antimalarial prescription 25 7.9 (3.6–16.7)
RDT-negative result 434  
  Any anti-malarial prescription (overtreatment) 44 10.2 (6.8–14.9)
First-line antimalarial prescription is defined as artemether or artesunate (oral, injection, or suppository) or ACT/AL (oral) prescription for an RDT-positive result. Second-line antimalarial prescription is defined as quinine (oral or injection), amodiaquine (oral), fansidar (oral), or other antimalarial (oral or injection) prescription for an RDT-positive result. Antimalarial undertreatment is defined as no antimalarial prescription for an RDT-positive result. Anti-malarial overtreatment is defined as any antimalarial prescription for an RDT-negative result. Point estimates are weighed to account for unequal probabilities of selection due to differing client volumes on the interview date. Standard error estimation accounted for clustering of client observations within facilities.
CI, confidence interval; RDT, rapid diagnostic tests.


Table 5.  Antibiotic prescriptions for clients with fever complaints, Malawi health facilities, 2013–2014
  N % with prescription (95% CI)
Fever complaint 1,981  
IMCI pneumonia assessment with result reported 1,367  
IMCI pneumonia positive classification 376  
  First-line antibiotic prescription 148 39.4 (32.3–46.9)
  Second-line antibiotic prescription 123 32.7 (26.3–39.8)
  No antibiotic prescription 105 27.9 (20.7–36.5)
‘Without antibiotic need’ 1,411  
  Any antibiotic prescription (overtreatment) 830 58.8 (55.1–62.4)
First-line antibiotic prescription is defined as benzyl penicillin injection or amoxicillin (capsules or syrup) for IMCI pneumonia. Second-line antibiotic prescription is defined as cotrimoxazole (syrup or tablets) or other antibiotics (injection, syrup, or capsule) for IMCI pneumonia. Antibiotic undertreatment is defined as no antibiotic prescription for IMCI pneumonia. Antibiotic overtreatment is defined as any antibiotic prescription ‘without antibiotic need’, or excluding clients with IMCI pneumonia (based on re-examination) and additionally excluding clients with the following diagnostic categories (recorded in the consultation): sepsis, dysentery, mastoiditis, acute ear infection, abscess, or severe malnutrition. Point estimates are weighed to account for unequal probabilities of selection due to differing client volumes on the interview date. Standard error estimation accounted for clustering of client observations within facilities. CI, confidence interval; IMCI, Integrated Management of Childhood Illness.

An analysis of influences on antibiotic overtreatment was conducted among 526 clients ‘without antibiotic need’ and with a reported RDT result using a model-based recursive partitioning approach. A crude mixed-effects logistic regression model was initially fit to the data set that indicated 16.8 (95% CI: 8.6–32.7) times higher odds of antibiotic overtreatment among RDT-negative clients than positive cases. Fig. 3 depicts all clients ‘without antibiotic need’, and the dark gray bars indicate those receiving any antibiotic drug or antibiotic overtreatment. The figure shows that CDB complaint was a statistically significant classifier learned through recursive partitioning. This split was largely driven by a difference in the underlying risk of antibiotic overtreatment across clients with or without CDB complaints rather than a difference in effect size across groups. Clients without CDB complaints and an RDT-positive result had very low risk of antibiotic overtreatment, and this risk increased with a negative test result. A similar pattern was found among clients with CDB complaints, although there was greater underlying risk of antibiotic overtreatment in this group. The highest risk of antibiotic overtreatment was found among clients with CDB complaints and an RDT-negative result. In this group, 82% of clients with RDT-negative results and CDB complaints were inappropriately prescribed antibiotics according to the study definition.

Fig 3

Fig. 3.   Interrelationship between RDT results and other variables on antibiotic overtreatment among clients with fever complaints, Malawi health facilities, 2013–2014.
Red lines indicate the effect size of RDT results on antibiotic overtreatment in each subgroup. Dark gray bars indicate any antibiotic prescription among clients ‘without antibiotic need’ referred to as antibiotic overtreatment. CDB refers to cough or difficult breathing complaint. AB refers to antibiotic. Results are derived from a model-based recursive partitioning approach that initially fit a mixed-effects logistic regression model to estimate the relationship between the RDT result and antibiotic overtreatment, and the influence of 38 other partitioning variables at patient, provider, and facility levels was learned through recursive partitioning conditional on the main predictor included in the model.

RDT perceptions and experiences in Mbarara District (Uganda)

In Mbarara District, health workers described various perceptions and challenges to using RDT for improved pediatric fever management, which highlight important facility readiness and clinical practice bottlenecks. Qualitative findings suggested that antimalarial medicines were commonly prescribed to RDT-negative results in this low transmission area if no alternative fever cause could be found. Malaria overtreatment also seemed driven by a combination of RDT perceptions, provider–client interactions, and system constraints that, in turn, elicited various dilemmas or feelings in health workers (Fig. 4).

Fig 4

Fig. 4.   Qualitative themes describing influences on managing non-malaria pediatric fevers in Mbarara District, Uganda.

RDT perceptions included a general RDT mistrust that was fueled by experiences of multiple testing, giving contradictory results (e.g. RDT negative but blood smear positive). This mistrust was also driven by expectations of false negative results in specific scenarios: low parasite or antigen loads, taking a recent antimalarial dose, or RDT detection of Plasmodium falciparum only. First, many health workers explained it would be difficult for a patient to receive a positive RDT result during early clinical symptoms (up to 3 days from fever onset) due to low parasite or antigen loads. Second, health workers talked about prescribing malaria treatment even if the RDTs were negative if the patient had recently taken an antimalarial dose. This was performed either to complete the treatment course and prevent ‘resistance in the child’ even if there were no detectable parasites or due to expectations of false negative results if an antimalarial was already present in the child’s system. Third, a few health workers noted that the RDT detects only P. falciparum and a false negative result could occur if the infection is caused by another parasite species.

Provider–client interactions included caregiver RDT mistrust and demand for certain medicines, as well as caregivers’ desires to know the ‘exact’ disease cause if not malaria. Moreover, many caregivers viewed doctors or hospitals as better equipped for differential diagnosis. System constraints included poor referral systems, working by themselves and not able to discuss difficult cases, as well as not having adequate skills or tools to differentiate among other fever causes. Various dilemmas or feelings were reported by respondents about managing these cases in light of these noted system constraints. Health workers expressed doubt about how best to manage these patients as well as feared doing wrong, loss of their patients to follow-up, or even patient death due to malaria. Many also worried that their services would be trusted less by patients, whereas others simply felt unsatisfied for not being able to provide a clear diagnosis to the sick patients.

Discussion

Overall, the PhD thesis highlighted low and inequitable testing rates for pediatric fevers across multiple sub-Saharan African countries in 2009–2011/12, with significant country differences in the effect of malaria diagnosis on antimalarial drug use patterns at the population level (Studies I and II). Health workers’ perceptions and practices impeded the use of malaria diagnosis for improved pediatric fever management in Uganda and Malawi (Studies III and IV), which needs to be addressed to improve quality fever care and rational use of both antimalarial and antibiotic drugs. Table 6 highlights policy recommendations stemming from the PhD thesis results.


Table 6.  Policy recommendations
Policy recommendations
Access
Deploy RDT to communities where pediatric fevers are commonly managed to achieve universal diagnosis goals
Expand integrated community case management to extend access to testing and care in an equitable manner
Facility readiness
Review IMCI guidelines to clarify antibiotic indications in the fever algorithm, particularly for RDT-negative cases
Integrate RDT and IMCI with combined guidelines, deployment, training, support, and monitoring in order to improve quality fever care and rational use of both antimalarials and antibiotics.
Clinical practice
Empower health workers at first-level facilities to manage non-severe non-malaria pediatric fevers without referral. This includes, at a minimum, building health worker and community trust in RDT-negative results, reinforcing skills in integrated care, and fostering communities of practice according to the diffusion of innovations theory.
RDT, rapid diagnostic tests; IMCI, Integrated Management of Childhood Illness.

Access

The PhD thesis found that testing rates were lowest among febrile children who were taken to lower or less formal sources of care where pediatric fevers are commonly managed, particularly by poorest families. This leads to an important socioeconomic dimension of malaria testing found in the PhD thesis, which occurs with other facility-based interventions as well (37). This is consistent with other research showing that the greatest contributor to reduced systems effectiveness for malaria case management is where care is sought for the sick child (38). Indeed, universal diagnosis goals will only be achieved if RDT deployment is targeted to those locations bearing the disproportionate burden of pediatric fever cases that are generally closer to communities. Such targeting would also help reduce significant inequities found in malaria diagnosis, which must be addressed going forward. Integrated community case management with RDT-based malaria diagnosis has been successfully piloted in a number of settings by both community health workers and drug shop owners (39, 40), and it is a promising approach for bringing quality care to remote areas underserved by the formal health system.

Facility readiness and clinical practice

In both Malawi and Uganda, there was poor integrated pediatric fever management using RDT and IMCI during outpatient consultations for sick children. In Malawi, few sick children were assessed for other fever causes despite a general adherence to RDT results. This included poor assessments of antibiotic need that led to suboptimal antibiotic prescription practices with both over- and undertreatments, which has been described in other settings as well (41, 42). The strong influence of RDT results on antibiotic overtreatment modified by CDB complaints highlights the primary importance of diagnostic test results and patient symptoms on clinical treatment decisions, which has also been described elsewhere (18, 19). These findings may reinforce concerns about growing irrational antibiotic prescription practices in the era of test-based malaria case management (43), particularly given etiology studies from Tanzania showing viral infections cause far more pediatric febrile illnesses than bacterial or parasitic infections (44, 45). As part of recent global commitments to combat antibiotic resistance (46), countries should consider better integration of RDT into IMCI guidelines to improve quality fever care, which could, in turn, improve rational use of both antimalarial and antibiotic drugs. IMCI guidelines should also clarify antibiotic indications in the fever algorithm, particularly for RDT-negative cases, which are currently unclear and could have contributed to antibiotic overtreatment found in this study (47), which has also been demonstrated elsewhere (42).

In Uganda (Mbarara District), health workers reported various challenges or perceptions that drove non-compliance to negative test results, including RDT perceptions, system constraints, and provider–client interactions, which must be addressed in order to improve program performance. Importantly, these stated constraints reflect notable ‘clusters of influence’ on the spread of new innovations or practices according to the diffusion of innovations theory – innovation perceptions, contextual factors, and user characteristics. This theory therefore holds great potential to inform the types of support mechanisms that could help overcome some of the facility readiness and clinical practices bottlenecks identified for Mbarara District and may be applicable to other settings.

Diffusion of innovations – from scientific advancement to effective delivery

The diffusion of innovations theory emerged in the 1960s, with Everett Rogers’ seminal work in rural sociology to understand why, how, and at what rate new innovations spread through a social group (48). Since then, this theory has been used across other disciplines, such as marketing, organizational behavior, and health promotion. There have also been efforts to apply this set of ideas to the uptake of new practices or innovations within health service delivery organizations (4852). More recently, these ideas were adapted to the RDT experience in sub-Saharan Africa (53), and the current PhD thesis further applied this theory to suggest ways for improving clinical practices in Mbarara District.

According to the diffusion of innovations theory, innovation perceptions play a large role in successful uptake of the new practice or innovation (4852). Five innovation perceptions may be most important: benefit, compatibility, simplicity, observability, and trialability. In Mbarara District, health workers described the benefits of malaria diagnosis and caregivers were reportedly eager to test their children. Yet, there were also perceived ‘risks’ in missing a malaria case that reduced these perceived benefits. These ‘risks’ should be explicitly acknowledged in training programs and ongoing support mechanisms to improve clinical practices. Similarly, health worker training and tools were not compatible with managing RDT-negative cases, and these clients were therefore not perceived as simple to manage. Trialability and observability are also important for adopters in order to have space to test new practices and to understand how others have incorporated these innovations into their work. Some authors further suggest that trialability and observability of new innovations are especially important for adopting ‘risky’ practices (48, 52).

User characteristics are also important for innovation uptake, and research highlights the central role of ‘opinion leaders’ within a social group to influence the opinion of their peers about the new practice (4650). Clinical officers could be natural ‘opinion leaders’ among health workers in Mbarara District, but some investment is needed to better connect ‘opinion leaders’ to their professional peers within the district and to further support their role as clinical team leaders, for example, through additional training and financial support. Moreover, evidence points to the importance of fostering informal exchanges among adopters within organizations in order to speed up successful practice adoption (4852). To this end, recent research found improved RDT adherence practices by facilitating communication among adopters, notably through daily short message service (SMS) reminders or interactive training sessions (54, 55). Other researchers have also proposed initiating Balint groups or peer-learning networks in order to foster communities of practice among health workers so that they could regularly discuss and problem-solve clinical practice issues (49, 56). An additional intervention for this district could be providing airtime to nurses for real-time consultations with ‘opinion leaders’ on difficult cases, which could also support such communities of practice.

Contextual factors, or system constraints, included weak referral systems, working by themselves and not able to discuss difficult cases, as well as not having adequate skills or tools to differentiate among other fever causes. Indeed, the ultimate objective should be to empower health workers at peripheral clinics to manage non-severe non-malaria fever cases without referral even within the context of a weak health system. As a top priority, RDT should be deployed as part of integrated treatment protocols, notably IMCI for sick children, in order to enhance health workers’ capacity to classify other potential fever causes. As described earlier, communities of practice could also potentially help reduce feelings of working alone without support or desires to refer test-negative patients for more advanced testing and care. Nevertheless, some overtreatment of dangerous diseases will – and arguably should – remain the norm in weak health systems, given understandable concerns that a patient may not return if symptoms worsen coupled with difficult referral for more advanced medical care.

Methodological limitations

There are a number of methodological issues across the four papers, which should be highlighted. First, the PhD thesis primarily relied on secondary analysis of public data sets that does not include in-depth data collection on any one topic. This resulted in missing information needed to help interpret results (e.g. malaria test type) or to construct confounding variables (e.g. illness severity), which is a particular problem in observational studies prone to residual confounding. Secondary analysis of these data sets also resulted in a time lag of a few years between data collection and published results, and our findings therefore reflect practices at the outset of new guidelines. Second, measurement errors may have occurred for various reasons, such as poor recall (e.g. caregiver reporting of test receipt or treatments prescribed) (57, 58) and purposeful misreporting (e.g. provider reporting RDT compliance to please interviewers in qualitative studies). Similarly, providers may also perform better under observation than in routine practice (59). Finally, Study III attempted to identify sick children who should not receive antibiotic prescriptions, which is difficult to measure in settings with inadequate diagnostics. Antibiotic need (or the lack thereof) was based on IMCI pneumonia indications and provider-reported diagnostic categories requiring antibiotics. This definition overestimates antibiotic need (or underestimates ‘without need’) because many children with these classifications or diagnoses will not have the underlying bacterial infection.

Conclusions

The four studies in this PhD thesis highlight important bottlenecks for using malaria diagnosis for improved pediatric fever management in terms of access, facility readiness, and clinical practice constraints, which must be addressed to improve program performance. RDT deployment should be targeted to community or facility sources of care, where febrile patients are commonly managed, in order to achieve universal diagnosis goals. There is also an urgent need to move beyond malaria-focused test and treat strategies toward IMCI with testing or test, classify and treat in order to improve quality fever care and rational use of both antimalarial and antibiotic drugs in line with recent commitments to combat resistance. Improved overall clinical care, including adherence to malaria test results, also requires stronger health systems, and RDT should be viewed as a unique entry point to support this important effort.

Author’s contributions

This PhD review was prepared by Emily White Johansson based on papers included in her doctoral thesis.

Acknowledgements

The author sincerely thanks her PhD supervisors for guidance provided for the PhD thesis and individual studies: Stefan Swartling Peterson, Katarina Ekholm Selling, Helena Hildenwall, and Max Petzold. She also gratefully acknowledges the contributions of other coauthors to these studies: Peter Gething (Studies I–III), Bonnie Mappin (Studies I–III), Freddy Kitutu (Study IV), Chrispus Mayora (Study IV), Phyllis Awor (Study IV), Henry Wamani (Study IV) and Humphreys Nsona (Study III).

Paper context

Despite major investments in malaria rapid diagnostic tests (RDTs), small-scale studies from limited countries have indicated poor RDT compliance. This thesis analyzed national surveys from a number of countries to provide large-scale evidence of diagnostic practices including determinants. Malaria testing was low and inequitable with poor RDT integration into clinical guidelines and common RDT mistrust. Going forward, RDT deployment must include integrated treatment protocols, RDT trust-building measures, and health system strengthening efforts to improve overall clinical practices.

References

  1. UNICEF (2014). Levels and trends in child mortality report 2014: estimates developed by the UN inter-agency group for child mortality estimation. New York: UNICEF.
  2. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al. Global, regional and national causes of child mortality in 2000–13 with projections to inform post-2015 priorities: an updated systematic review. Lancet 2015; 385: 430–40. Publisher Full Text
  3. Jones G, Steketee R, Black RE, Bhutta ZA, Morris S. How many child deaths can we prevent this year? Lancet 2003; 362: 65–71. Publisher Full Text
  4. WHO (1991). The overlap in the clinical presentation and treatment of malaria and pneumonia in children: report of a meeting. Geneva: WHO.
  5. WHO, UNICEF. Integrated management of childhood illness: a WHO/UNICEF initiative. Bull World Health Organ 1997; 75: 5–128.
  6. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004; 329: 1212. Publisher Full Text
  7. English M, Punt J, Mwangi I, McHugh K, Marsh K. Clinical overlap between malaria and severe pneumonia in African children in hospital. Trans Roy Soc Trop Med Hyg 1996; 90: 658–62. Publisher Full Text
  8. Källander K, Hildenwall H, Waiswa P, Galiwango E, Peterson S, Pariyo G. Delayed care seeking for fatal pneumonia in children aged under five years in Uganda: a case series study. Bull World Health Organ 2008; 86: 332–8. Publisher Full Text
  9. WHO (2012). T3: test. Treat. Track. Scaling up diagnostic testing, treatment and surveillance for malaria. Geneva: WHO.
  10. WHO (2010). Guidelines for the treatment of malaria. Geneva: WHO.
  11. Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect 2010; 16: 1062–9. Publisher Full Text
  12. WHO (2001). Drug resistance in malaria. Geneva: WHO.
  13. Institute of Medicine (2004). Saving lives buying time – economics of malaria drugs in the age of resistance. Washington, DC: National Academies Press.
  14. O’Meara W, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis 2010; 10: 545–55. Publisher Full Text
  15. Zhao J, Lama M, Korenromp E, Aylward P, Shargie E, Filler S, et al. Adoption of rapid diagnostic tests for the diagnosis of malaria, a preliminary analysis of the Global Fund program data, 2005 to 2010. PLoS One 2012; 7: e43549. Publisher Full Text
  16. Bastiaens GJH, Bousema T, Leslie T. Scale-up of malaria rapid diagnostic tests and artemisinin-based combination therapy: challenges and perspectives in sub-Saharan Africa. PLoS Med 2014; 11: e1001590. Publisher Full Text
  17. Skarbinski J, Ouma PO, Causer LM, Kariuki SK, Barnwell JW, Alaii JA, et al. Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial. Am J Trop Med Hyg 2009; 80: 919–26.
  18. Msellem MI, Mårtensson A, Rotllant G, Bhattarai A, Strömberg J, Kahigwa E, et al. Influence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar: a crossover validation study. PLoS Med 2009; 6: e100070. Publisher Full Text
  19. Steinhardt L, Chinkhumba J, Wolkon A, Luka M, Luhanga M, Sande J, et al. Patient-, health worker-, and health facility-level determinants of correct malaria case management at publicly funded health facilities in Malawi: results from a nationally representative health facility survey. Malar J 2014; 13: 64. Publisher Full Text
  20. Keating J, Finn TP, Eisele TP, Dery G, Biney E, Kedote M, et al. An assessment of malaria diagnostic capacity and quality in Ghana and the Republic of Benin. Trans Roy Soc Trop Med Hyg 2014; 108: 662–9. Publisher Full Text
  21. Kitutu FE, Mayora C, Awor P, Forsberg B, Peterson S, Wamani H. Inclusion of private sector in district health systems: case study of private drug shops implementing the modified integrated community case management (iCCM) strategy in rural Uganda. BMC Health Serv Res 2014; 14: 65. Publisher Full Text
  22. dhsprogram.com. Calverton MD: The DHS Program; 2016 [updated 24 March 2016]. Available from: http://dhsprogram.com [cited 18 April 2014].
  23. dhsprogram.com. Calverton MD: Service Provision Assessments; 2016 [updated 24 March2016]. Available from: http://dhsprogram.com/What-We-Do/Survey-Types/SPA.cfm [cited 18 April 2014].
  24. International Health Partnership (2011). Monitoring, evaluation and review of national health strategies: a country-led platform for information and accountability. Geneva: WHO.
  25. Baker U, Peterson S, Marchant T, Mbaruku G, Temu S, Manzi F, et al. Identifying implementation bottlenecks for maternal and newborn health interventions in rural districts of the United Republic of Tanzania. Bull World Health Organ 2015; 93: 380–9. Publisher Full Text
  26. Johansson E, Gething P, Hildenwall H, Mappin B, Petzold M, Peterson S, et al. Diagnostic testing of pediatric fevers: meta-analysis of 13 national surveys assessing influences of malaria endemicity and source of care on test uptake for febrile children under five years. PLoS One 2014; 9: e95483. Publisher Full Text
  27. Johansson E, Gething P, Hildenwall H, Mappin B, Petzold M, Peterson S, et al. Effect of diagnostic testing on medicines used by febrile children less than five years in 12 malaria-endemic African countries: a mixed-methods study. Malar J 2015; 14: e95483. Publisher Full Text
  28. Johansson E, Kitutu F, Mayora C, Awor P, Peterson S, Wamani H, et al. ‘It could be viral but you don’t know, you have not diagnosed it’. Health worker challenges in managing non-malaria pediatric fevers in the low transmission setting of Mbarara District, Uganda. Malar J 2016; 15: 197. Publisher Full Text
  29. Johansson E, Selling K, Nsona H, Mappin B, Gething P, Petzold M, et al. Integrated pediatric fever management and antibiotic over-treatment in Malawi health facilities: data mining a national facility census. Malar J 2016; 15: 396. Publisher Full Text
  30. Government of Uganda, Bureau of Statistics and Ministry of Health (2015). Malaria indicator survey 2014–2015 – key indicators. Kampala: Government of Uganda.
  31. Government of Uganda, Ministry of Health (2015). Health sector strategic plan 2010/11–2014/15. Kampala: Government of Uganda.
  32. Republic of Uganda (2009). Uganda national malaria strategic plan 2010/11–2014/15. Kampala: Government of Uganda.
  33. Yin R. Case study research: design and methods. 4th ed. Thousand Oaks, CA: Sage; 2009.
  34. Fokkema M, Smits N, Zeileis A, Hothorn T, Kelderman H. Detecting treatment sub-group interactions in clustered data with generalized linear mixed-effects model trees. Working Paper in Economics and Sstatistics. Innsbruck: University of Innsbruck; 2015.
  35. Zeileis A, Hothorn T, Hornik K. Model-based recursive partitioning. J Comp Graph Stat 2008; 17: 492–514. Publisher Full Text
  36. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 2004; 24: 105–12. Publisher Full Text
  37. Gabrysch S, Cousens S, Cox J, Campbell OMR. The influence of distance and level of care on delivery place in rural Zambia: a study linked national data in a geographic information system. PLoS Med 2011; 8: e1000394. Publisher Full Text
  38. Littrell M, Miller JM, Ndhlovu M, Hamainza B, Hawela M, Kamuliwu M, et al. Documenting malaria case management coverage in Zambia: a systems effectiveness approach. Malar J 2013; 12: 371. Publisher Full Text
  39. Awor P, Wamani H, Tylleskar T, Peterson S. Drug seller adherence to clinical protocols with integrated management of malaria, pneumonia and diarrhea at drug shops in Uganda. Malar J 2015; 14: 277. Publisher Full Text
  40. Mukanga D, Tibenderana JK, Peterson S, Pariyo G, Kiguli J, Waiswa P, et al. Access, acceptability and utilization of community health workers using diagnostics for case management of fever in Ugandan children: a cross-sectional study. Malar J 2012; 11: 121. Publisher Full Text
  41. Senn N, Rarau P, Salib M, Manong D, Siba P, Rogerson S, et al. Use of antibiotics within the IMCI guidelines in outpatient settings in Papua New Guinean children: an observational and effectiveness study. PLoS One 2014; 9: e90990. Publisher Full Text
  42. Shao AF, Rambaud-Althaus C, Samaka J, Faustine AF, Perri-Moore S, Swai N, et al. New algorithm for managing childhood illness using mobile technology (ALMANACH): a controlled non-inferiority study on clinical outcome and antibiotic use in Tanzania. PLoS One. 2015; 10: e0132316. Publisher Full Text
  43. Baiden F, Webster J, Owusu-Agyei S, Chandromohan D. Would rational use of antibiotics be compromised in the era of test-based malaria case management? Trop Med Int Health 2013; 16: 142–4. Publisher Full Text
  44. D’Acremont V, Kilowoko M, Kyungu E, Philipina S, Sangu W, Kahama-Maro J, et al. Beyond malaria – causes of fever in outpatient Tanzanian children. N Engl J Med 2014; 370: 809–17. Publisher Full Text
  45. Hildenwall H, Amos B, Mtove G, Muro F, Cederlund K, Reyburn H. Causes of non-malaria febrile illness in outpatients in Tanzania. Trop Med Int Health 2015; 21: 149–56. Publisher Full Text
  46. WHO (2015). World Health Assembly resolution A68/20 – global action plan on antimicrobial resistance. Geneva: WHO.
  47. WHO (2014). Integrated management of childhood illness – chart booklet. Geneva: WHO.
  48. Rogers EM. Diffusion of innovations. New York: Free Press of Glencoe; 1962.
  49. Greenhalgh T, Robert G, MacFarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q 2004; 82: 581–629. Publisher Full Text
  50. Institute for the Future: Diffusion of innovation in health care. Oakland, CA: California Health Care Foundation; 2002.
  51. Dearing JW. Applying diffusion of innovation theory to intervention development. Res Soc Work Pract 2009; 19: 503–18. Publisher Full Text
  52. Berwick DM. Disseminating innovations in health care. JAMA 2003; 289: 1969–75. Publisher Full Text
  53. Chandler CIR, Whitty CJM, Ansah EK. How can malaria rapid diagnostic tests achieve their potential? A qualitative study of a trial at health facilities in Ghana. Malar J 2010; 9: 95. Publisher Full Text
  54. Modrek S, Schatzin E, De La Cruz A, Isiguzo C, Nwokolo E, Anyanti J, et al. SMS messages increase adherence to rapid diagnostic test results among malaria patients: results from a pilot study in Nigeria. Malar J 2014; 13: 69. Publisher Full Text
  55. Mbacham WF, Mangham-Jeffries L, Cundill B, Achonduh OA, Chandler CIR, Ambebila JN, et al. Basic or enhanced clinician training to improve adherence to malaria treatment guidelines: a cluster- randomized trial in two areas of Cameroon. Lancet Glob Health 2014; 2: e346–58. Publisher Full Text
  56. Wenger E. Communities of practice: learning, meaning and identity. Cambridge: Cambridge University Press; 1998.
  57. Eisele TP, Silumbe K, Yukich J, Hamainza B, Keating J, Bennett A, et al. Accuracy of measuring diagnosis and treatment of childhood malaria from household surveys in Zambia. PLoS Med 2013; 10: e1001417. Publisher Full Text
  58. Hildenwall H, Lindkvist J, Tumwine JK, Bergqvist Y, Pariyo G, Tomson G, et al. Low validity of caretakers’ reports on use of selected antimalarials and antibiotics in children with severe pneumonia at an urban hospital in Uganda. Trans Roy Soc Trop Med Hyg 2009; 103: 95–101. Publisher Full Text
  59. Leonard K, Masatu MC. Outpatient process quality evaluation and the Hawthorne Effect. Soc Sci Med 2006; 63: 2330–40. Publisher Full Text
About The Author

Emily White Johansson
Uppsala University, Department of Women's and Children's Health
Sweden

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Related Content